Foresite Capital Management Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$1.4B
Industry:VC/PE
Founded:N/A
Lead Investor(s):Limited partners in Fund IV

Industry Ranking

Estimated Revenue & Financials

  • Foresite Capital Management received $668.0M in venture funding in May 2018.
  • Foresite Capital Management's total funding is $1.4B.

Employee Data

  • Foresite Capital Management has 53 Employees.
  • Foresite Capital Management grew their employee count by 2% last year.
  • Foresite Capital Management currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A32N/AN/A-N/A
#2
N/A15018%N/A-N/A
#3
N/A2347%N/A-N/A
#4
N/A304N/AN/A-N/A
#5
N/A1250%N/A-N/A
#6
N/A19N/AN/A-N/A
#7
N/A18N/AN/A-N/A
#8
N/A4316%N/A-N/A
#9
N/A19N/AN/A-N/A
#10
N/A7037%N/A-N/A
Missing a competitor? Contribute!?
Submit

Foresite Capital is a multi-stage healthcare and life sciences investment firm that applies rigorous scientific and data-driven approaches to investment analysis. The firm has $2.2 billion in assets under management. Foresite Capital takes a collaborative approach to investing with its portfolio companies by providing a multidisciplinary team of scientists, engineers, analysts, and clinicians who understand the unique business models in healthcare in addition to capital. The company aims to address areas of great unmet clinical need over the long term by funding promising healthcare and life sciences businesses at all stages of their life cycles. Its portfolio also emphasizes companies that are employing the tools of data science and machine intelligence in healthcare. Foresite Capital is based in San Francisco with an office in New York.

keywords:Finance,Healthcare,Pharmaceuticals

53

Number of Employees

N/A

Revenue (est)

1

Current Jobs

2%

Employee Growth %

$1.4B

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Foresite Capital Management News

09/03/2019 - Foresite Capital Management Ii Purchases 15,700 Shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) Stock

Aerie Pharmaceuticals Inc (NASDAQ:AERI) major shareholder Foresite Capital Management Ii bought 15,700 shares of the firm's stock in a ...

09/08/2019 - Immunomedics, Inc. (NASDAQ:IMMU) Position Trimmed by Foresite Capital Management III LLC

Foresite Capital Management III LLC reduced its position in shares of Immunomedics, Inc. (NASDAQ:IMMU) by 19.3% in the 2nd quarter, ...

09/03/2019 - Foresite Capital Management III LLC Grows Position in Natera Inc (NASDAQ:NTRA)

Foresite Capital Management III LLC boosted its position in shares of Natera Inc (NASDAQ:NTRA) by 13.6% during the 2nd quarter, according ...

Foresite Capital Management Funding

DateAmountRoundLead InvestorsReference
2014-04-02$300.0MUndisclosedArticle
2015-07-30$450.0MThirdArticle
2018-05-04$668.0MFourthLimited partners in Fund IVArticle

Foresite Capital Management Executive Hires

DateNameTitleReference
2017-04-25Molly HeVenture PartnerArticle
2018-12-12Nick SmithHead of investor relationsArticle